CRO Quality Benchmarking – Phase II/III Service Providers (12th Edition)

Description

When it comes to the complex world of clinical trials, it takes a village. And a lot of that village is outsourced. Whether you’re a veteran or new to the business of clinical trials, we at ISR aim to take two of the most challenging and time-consuming processes out of the abstract: CRO selection and CRO performance evaluation. Which provider is best to conduct a given trial? Who will perform the best? With more than a decade of this type of research under our belts, we provide a wealth of information in the form of this quality benchmarking report to address these questions. The goal? To take the mystery and stress out of your Phase II/III service provider selection process. Informed decisions are the best decisions.


Both sponsors and providers can use this research to glean what they need to make the best decisions possible for their clinical development programs and service offerings. Go ahead, de-mystify your Phase II/III provider selection and evaluation processes.

Sponsors:

  • Discover which service providers your company should consider for your clinical development programs by seeing how your peers’ expectations line up with individual CROs
  • Gain insight into CRO customer loyalty based on overall customer satisfaction, willingness to recommend and likelihood to use again
  • Learn which Phase II/III-specific attributes drive outsourcing selection, and explore verbatim responses from recent customers on CRO performance

Service Providers:

  • Compare how your company matches up against your competitors across 21 attributes grouped by Budget, Delivery, Staff and Services
  • Learn how to improve your marketing messaging by focusing on the areas in which customers say you excel compared to the competition
  • Find out which factors affect sponsor outsourcing preferences, and which factors are gaining in importance for future outsourcing
  • Service Provider Selection Process
  • Service Provider Perceptions and Interactions
  • Service Provider Performance and Loyalty
  • Company Service Quality Profiles

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.

Service Provider Selection Process

Primary Section Takeaways
Preferred Provider Agreements
Selection Attributes
Use of Outside Consultants

Service Provider Perceptions and Interactions

Primary Section Takeaways
Phase II/III Leadership, Familiarity, and Use
Service Provider Preference
Service Provider Preference among Users
Cost Perceptions
Cost Experience among Users
Summary Table

Service Provider Performance and Loyalty

Primary Section Takeaways
A Note on Harvey Ball Calculations
Performance Across Service Providers
Figure 1 – Budget Factors
Figure 2 – Delivery Factors
Figure 3 – Staff Characteristics
Figure 4 – Services
Customer Loyalty: 2020
Customer Loyalty: 3-Year Rolling Average
Company Service Quality Profiles

Bioclinica
Covance
Eurofins
ICON
IQVIA
Medpace
Parexel
PPD
PRA
Premier Research
Syneos Health
Worldwide Clinical Trials

Study Data

Phase II/III Leaders, Unprompted
Phase II/III Leaders, Prompted
Service Provider Familiarity
Service Provider Usage
Service Provider Preference
Service Provider Differentiation
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
Selection Drivers: Selecting among Preferred Providers
Preferred Provider Attributes Gaining Importance
Selection Drivers: When Not Using Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance: No Preferred Providers
Use of Outside Consultants
Outside Consultant Assistance
Service Provider Drill-downs

Advanced Clinical
Bioclinica
Biorasi
Bioskin
Catalyst Clinical Research
Clinical Research Services (CRS)
Clinipace
Clintec
Covance
CTI Clinical Trial & Consulting
DaVita Clinical Research
DCRI-Duke
Eurofins
Frontage
ICON
Innovaderm
IQVIA
Lambda
Linical Accelovance
Medpace
Medsource
NAMSA
Navitas Life Sciences
Novotech
Ora
PAREXEL
Pharm-Olam International
PharPoint
PPD
PRA
PRC Clinical
Premier Research
PSI
QPS
Quanticate
Rho
SGS Life Sciences
Syneos Health
Synteract
Worldwide Clinical Trials

Demographics

Company Type
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement by Phase
Involvement in Clinical Development
Therapeutic Areas of Responsibility
Years of Industry Experience
Age

Additional information

License

, ,